Skip to main content

Table 3 Direct cost (test and treatment cost) and comprehensive cost (including estimate of life value) of the presumptive versus the test based strategy at "real life" adherence levels to both strategies (see text): test and treatment cost not subsidized

From: Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso

Variables

Children, dry season

Children, rainy season

Adults, dry season

Adults, rainy season

Direct cost, presumptive strategy

1032

1033

2005

2048

Direct cost, test-based strategy

1713

1767

2699

2758

Comprehensive cost, presumptive strategy

1747

1372

2728

2604

Comprehensive cost, test-based strategy

2615

2284

3369

3271

Threshold life value*

n.a. (test dominated)

n.a. (test dominated)

6958

9071

  1. Costs expressed in € (euro) for 1000 patients managed with either strategy, assuming a life value of 525 € (better option in bold)
  2. * Life value at which the two strategies become equivalent at sensitivity analysis